Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response

Mostrar otras versiones (1)

A detailed understanding of the molecular features of the neutralizing epitopes developed by viral escape mutants is important for predicting and developing vaccines or therapeutic antibodies against continuously emerging SARS-CoV-2 variants. Here, we report three human monoclonal antibodies (mAbs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Anamika, Kumar, Sanjeev, Lai, Lilin, Chakravarthy, Chennareddy, Valanparambil, Rajesh, Reddy, Elluri Seetharami, Gottimukkala, Kamalvishnu, Bajpai, Prashant, Raju, Dinesh Ravindra, Edara, Venkata Viswanadh, Davis-Gardner, Meredith E., Linderman, Susanne, Dixit, Kritika, Sharma, Pragati, Mantus, Grace, Cheedarla, Narayanaiah, Verkerke, Hans P., Frank, Filipp, Neish, Andrew S., Roback, John D., Davis, Carl W., Wrammert, Jens, Ahmed, Rafi, Suthar, Mehul S., Sharma, Amit, Murali-Krishna, Kaja, Chandele, Anmol, Ortlund, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628201/
https://www.ncbi.nlm.nih.gov/pubmed/36324804
http://dx.doi.org/10.1101/2022.10.24.513517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628201/
https://www.ncbi.nlm.nih.gov/pubmed/36324804
http://dx.doi.org/10.1101/2022.10.24.513517

Ejemplares similares